Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

IART

$16.03

Updated: 22/09/2026, 18:58:53

Market Cap
$1.25B
Sector
Healthcare
Industry
Medical - Devices
Country
US
Stock valuation chart
One-year closing share-price history for IART
Company Profile

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

USD
NASDAQ
CEO: Stuart Essig
Employees: 4,427
https://www.integralife.com
Asset Summaries
Latest generated summaries for IART

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for IART.
Share price
$16.03
Market cap
$1.25B
Exchange
NASDAQ
Currency
USD
CEO
Stuart Essig
Employees
4,427
IPO date
16/08/1995
Beta
1.213
Last dividend
$0.00
Day range
$15.69 – $16.30
52-week range
$8.70 – $20.49
1-day performance
2.85%
1-year performance
84.31%
Current drawdown (1Y)
-21.74%
CIK
0000917520
CUSIP
457985208
ISIN
US4579852082
Created
07/12/2025, 04:38:20
Last update
22/09/2026, 18:58:53

Track Integra LifeSciences Holdings Corporation with an AI analyst

See which prediction-market events move IART, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to IART from your Railway `news_articles` table.

Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term

Zacks Investment Research • STOCK • 09/06/2026, 12:41:19

IART vs. MASI: Which Stock Should Value Investors Buy Now?

Zacks Investment Research • STOCK • 03/06/2026, 14:41:08

Integra LifeSciences Holdings Corporation (IART) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research • STOCK • 29/05/2026, 12:16:12

Integra LifeSciences (IART) is a Top-Ranked Value Stock: Should You Buy?

Zacks Investment Research • STOCK • 22/05/2026, 12:41:16

IART or MASI: Which Is the Better Value Stock Right Now?

Zacks Investment Research • STOCK • 18/05/2026, 14:41:19

Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term

Zacks Investment Research • STOCK • 18/05/2026, 12:50:22

Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears

MarketBeat • STOCK • 17/05/2026, 20:03:41

Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 12/05/2026, 23:50:50

Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference

GlobeNewsWire • STOCK • 08/05/2026, 10:00:00

Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 05/05/2026, 16:51:22

Integra LifeSciences Announces Leadership Transition

GlobeNewsWire • STOCK • 05/05/2026, 08:00:00

Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock

Zacks Investment Research • STOCK • 23/04/2026, 12:51:53